C. Dominici

发表

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma

S. Annavarapu, S. Cialfi, C. Dominici, 2013, Laboratory Investigation.

A Pilot Study of 5‐Day Continuous Infusion of High‐Dose Cisplatin and Pulsed Etoposide in Childhood Solid Tumors

C. Dominici, M. Castello, A. Clerico, 1988 .

Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors

R. Boldrini, I. Screpanti, C. Dominici, 2014, Cell Death and Disease.

Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: Pharmacological rationale and clinical response

A. Jenkner, A. Donfrancesco, S. Cialfi, 2010, Pediatric blood & cancer.

MiR‐128 up‐regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness

Giuseppe Giannini, C. Dominici, H. McDowell, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Neuroblastoma: contemporary management

C. Dominici, H. McDowell, D. Mullassery, 2009, Archives of Disease in Childhood: Education & Practice Edition.

Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients

R. Boldrini, C. Dominici, H. McDowell, 2008, Clinical Cancer Research.

c‐Kit is preferentially expressed in MYCN‐amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI‐571

Roberta Vitali, A. Donfrancesco, C. Dominici, 2003, International journal of cancer.

Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group.

A. Jenkner, F. Berthold, C. Dominici, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Deferoxamine, Cyclophosphamide, Etoposide, Carboplatin, and Thiotepa (D‐CECaT): A New Cytoreductive Chelation‐Chemotherapy Regimen in Patients with Advanced Neuroblastoma

A. Donfrancesco, C. Dominici, A. Amici, 1992, American journal of clinical oncology.

Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.

C. Dominici, G. Raschellà, M. Castello, 1993, Cancer research.

Increased sensitivity to the platelet‐derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF‐BB‐mediated signaling and STI571‐induced Akt inactivation

C. Dominici, R. Riccardi, M. Sanguinetti, 2006, Journal of cellular physiology.

Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors.

C. Dominici, H. McDowell, A. Pinchera, 2006, Cancer genetics and cytogenetics.

PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines

C. Dominici, S. Ceccarelli, A. Pizzuti, 2018, Journal of Cancer Research and Clinical Oncology.

Temozolomide in resistant or relapsed pediatric solid tumors

A. Jenkner, A. Donfrancesco, C. Dominici, 2006, Pediatric blood & cancer.

Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models

C. Dominici, H. McDowell, R. Riccardi, 2006 .

In vivo and In vitro Neuroblastoma Cells Activity by NVP-AEW 541 Has an Antitumor Effect on Down-Regulation of Insulin-Like Growth Factor I Receptor

C. Dominici, H. McDowell, B. Tanno, 2006 .

Down-Regulation of Insulin-Like Growth Factor I Receptor Activity by NVP-AEW541 Has an Antitumor Effect on Neuroblastoma Cells In vitro and In vivo

C. Dominici, H. McDowell, G. Raschellà, 2006, Clinical Cancer Research.

Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma

I. Bozzoni, C. Dominici, I. Legnini, 2019, Oncogene.

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells

C. Dominici, S. Ceccarelli, H. McDowell, 2017, Journal of Hematology & Oncology.

Noonan syndrome‐like disorder with loose anagen hair: A second case with neuroblastoma

C. Dominici, S. Bernasconi, M. Tartaglia, 2015, American journal of medical genetics. Part A.

Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines

C. Dominici, A. Lenzi, C. Crescioli, 2019, Journal of Endocrinological Investigation.

Prolonged Response to Oral Gefitinib, Cyclophophamide, and Topotecan in Heavily Pretreated Relapsed Stage 4 Neuroblastoma: A Case Report

A. Jenkner, A. Donfrancesco, C. Dominici, 2007, Journal of pediatric hematology/oncology.

Long-term Follow-up of the “Wait and See” Approach to Localized Perinatal Adrenal Neuroblastoma

C. Dominici, A. Clerico, A. Schiavetti, 2013, World Journal of Surgery.

Ifosfamide/carboplatin/etoposide (ICE) as front‐line, topotecan/ cyclophosphamide as second‐line and oral temozolomide as third‐line treatment for advanced neuroblastoma over one year of age

R. Cozza, A. Jenkner, A. Donfrancesco, 2004, Acta paediatrica (Oslo, Norway : 1992). Supplement.

A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors.

A. Jenkner, C. Dominici, M. Castello, 1990, Pediatric hematology and oncology.

Bim-dependent apoptosis follows IGFBP-5 down-regulation in neuroblastoma cells.

C. Dominici, G. Raschellà, B. Tanno, 2006, Biochemical and biophysical research communications.

Expression of Glial Cell Line-Derived Neurotrophic Factor and Neurturin in Mature Kidney, Nephrogenic Rests, and Nephroblastoma: Possible Role as Differentiating Factors

F. Camassei, A. Jenkner, L. Ravà, 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Id 2 Is Critical for Cellular Proliferation and Is the Oncogenic Effector of N-Myc in Human Neuroblastoma 1

A. Donfrancesco, R. Boldrini, A. Iavarone, 2001 .

Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.

A. Donfrancesco, R. Boldrini, A. Iavarone, 2002, Cancer research.

HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.

C. Dominici, H. McDowell, C. Crescioli, 2017, Cancer letters.

Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients.

S. Cialfi, C. Dominici, A. Pizzuti, 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.

A. Donfrancesco, C. Dominici, M. Castello, 1990, The American journal of pediatric hematology/oncology.

Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88.

C. Dominici, G. Basso, V. Ninfo, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High mobility group A1 is a molecular target for MYCN in human neuroblastoma.

I. Screpanti, C. Dominici, G. Giannini, 2005, Cancer research.

Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.

C. Dominici, B. Calabretta, S. Pucci, 1994, Cancer research.

Cytomegalovirus-associated stage 4S neuroblastoma relapsed stage 4.

C. Dominici, J. Booth, M. Castello, 1995, Medical and pediatric oncology.

Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model

C. Dominici, B. Calabretta, G. Raschellà, 2009, International journal of cancer.

Correlation between Tyrosine Hydroxylase Immunoreactive Cells in Tumors and Urinary Catecholamine Output in Neuroblastoma Patients

C. Dominici, C. Cappelli, D. Lomanto, 1986, Tumori.

Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.

A. Donfrancesco, C. Dominici, M. Carli, 2001, Medical and pediatric oncology.

Cytogenetic, Molecular, Immunologic, and Ultrastructural Study on an Established Cell Line of a Stage III Neuroblastoma

C. Dominici, G. D’Orazi, A. Modesti, 1988 .

Synergistic Post-Transcriptional Regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 Specific Binding

S. Cialfi, C. Dominici, A. Pizzuti, 2011, PloS one.

Establishment and characterization of a human neuroblastoma cell line

C. Dominici, G. Forni, A. Modesti, 1989, International Journal of Cancer.

Transcription of N-myc and proliferation-related genes is linked in human neuroblastoma.

S. Ferrari, C. Dominici, G. Raschellà, 1991, Cancer letters.

Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition

C. Dominici, S. Ceccarelli, H. McDowell, 2015, Journal of experimental & clinical cancer research : CR.

Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members

S. Cialfi, C. Dominici, H. McDowell, 2014, BMC Cancer.

RAS signaling dysregulation in human embryonal Rhabdomyosarcoma

C. Dominici, G. Kokai, S. Uccini, 2009, Genes, chromosomes & cancer.

Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition

C. Dominici, S. Ceccarelli, H. McDowell, 2015, Journal of Experimental & Clinical Cancer Research.

Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.

C. Dominici, M. Rydén, C. Ibáñez, 1997, European journal of cancer.

Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.

C. Dominici, M. Rydén, C. Ibáñez, 1996, British Journal of Cancer.

Malignant Pancreatic Endocrine Tumor in a Child With Tuberous Sclerosis

R. Boldrini, C. Dominici, A. Giannotti, 2003, The American journal of surgical pathology.

A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma

S. Cialfi, C. Dominici, H. McDowell, 2017, Oncology reports.

The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform.

M. L. Belli, S. Cialfi, C. Dominici, 2012, Neoplasia.

The p 53 Codon 72 Pro / Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients : Correlation with Reduced Apoptosis and Enhanced Senescence by the p 53-72 P Isoform 1 , 2

M. L. Belli, S. Cialfi, C. Dominici, 2012 .

NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance

C. Dominici, A. Fioravanti, L. Pirtoli, 2019, Journal of Cancer Research and Clinical Oncology.

Slug (SNAI2) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma Preclinical Models

C. Dominici, B. Calabretta, G. Bossi, 2008, Clinical Cancer Research.

N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.

J. Bourhis, C. Dominici, H. McDowell, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience.

C. Dominici, G. Tonini, R. Sansone, 1991, Cancer genetics and cytogenetics.

Association of near-diploid DNA content and N-myc amplification in neuroblastomas

C. Dominici, G. Raschellà, F. Mauro, 1989, Clinical & Experimental Metastasis.

Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome

C. Dominici, S. Uccini, P. Radice, 2008, Pediatric blood & cancer.

Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide.

Roberta Vitali, C. Dominici, B. Calabretta, 2008, Biochemical and biophysical research communications.

Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma.

C. Dominici, R. Haupt, R. Luksch, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma

A. Donfrancesco, C. Bosman, C. Dominici, 2004, Journal of Neuro-Oncology.

Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma.

A. Donfrancesco, C. Dominici, P. Natali, 1995, European journal of cancer.

with Favorable Prognosis Low Affinity Nerve Growth Factor Receptor in Neuroblastoma Protooncogene and TRK Coexpression of Messenger RNA for Updated Version

C. Dominici, Giuseppe, M. Castello, 2006 .

Primary pulmonary rhabdomyosarcoma in childhood: clinico-biologic features in two cases with review of the literature.

C. Dominici, M. Castello, A. Schiavetti, 1996, Medical and pediatric oncology.

Effects of a single course of deferoxamine in neuroblastoma patients.

A. Donfrancesco, C. Dominici, M. Castello, 1990, Cancer research.

Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.

A. Donfrancesco, R. Boldrini, C. Dominici, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase.

C. Dominici, C. Cappelli, S. Pucci, 1992, Anticancer research.

Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

A. Donfrancesco, C. Dominici, G. Tonini, 2003, Virchows Archiv.

Bone marrow micrometastases in a patient with localized Wilms' tumor.

C. Dominici, M. Castello, A. Padula, 1996, Medical and pediatric oncology.

MYCN Sensitizes Human Neuroblastoma to Apoptosis by HIPK2 Activation through a DNA Damage Response

I. Screpanti, C. Dominici, H. McDowell, 2010, Molecular Cancer Research.

Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours

A. Donfrancesco, R. Boldrini, C. Dominici, 2006, British Journal of Cancer.

Wilms’ Tumor—Lessons and Outcomes—A 25-Year Single Center UK Experience

C. Dominici, H. McDowell, D. Fawkner-Corbett, 2014, Pediatric hematology and oncology.

MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1

R. Mancini, C. Dominici, S. Ceccarelli, 2020, Journal of Experimental & Clinical Cancer Research.

MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1

R. Mancini, C. Dominici, S. Ceccarelli, 2020, Journal of Experimental & Clinical Cancer Research.

Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells

I. Screpanti, C. Dominici, G. Giannini, 2012, PloS one.

Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience

C. Dominici, P. Papoff, A. Schiavetti, 2019, Child's Nervous System.

High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high‐risk ewing sarcoma family tumors

R. Cozza, A. Jenkner, A. Donfrancesco, 2006, Cancer.

DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation

C. Dominici, S. Ceccarelli, H. McDowell, 2016, Oncotarget.

Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells

C. Dominici, C. Leonetti, M. Porru, 2015, Oncotarget.

Vascular endothelial growth factor serum levels in children with newly diagnosed rhabdomyosarcoma

C. Dominici, H. McDowell, A. Antenucci, 2012, Pediatric blood & cancer.

BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells.

C. Dominici, S. Ceccarelli, A. Pizzuti, 2020, Cancer letters.

Somatostatin in neuroblastoma and ganglioneuroma.

C. Dominici, E. Theodorsson, H. Jacobsson, 1997, European journal of cancer.

Slug ( SNAI 2 ) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma

C. Dominici, B. Calabretta, G. Bossi, 2008 .

D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age.

A. Donfrancesco, C. Dominici, J. Uchino, 1995, Anticancer research.

Clinical Significance of CXC Chemokine Receptor-4 and c-Met in Childhood Rhabdomyosarcoma

A. Donfrancesco, F. Callea, C. Dominici, 2008, Clinical Cancer Research.

Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members

S. Cialfi, C. Dominici, H. McDowell, 2014, BMC Cancer.

Detection and clinical significance of disseminated tumour cells at diagnosis in bone marrow of children with localised rhabdomyosarcoma.

R. Cozza, A. Donfrancesco, R. Boldrini, 2005, European journal of cancer.

Peripheral blood stem cells in children with solid tumors. Part II. Immunocytologic detection of tumor cells in bone marrow and peripheral blood stem cell harvests.

A. Donfrancesco, C. Dominici, A. Angioni, 1993, Anticancer research.

Antitumor activity of imatinib mesylate in neuroblastoma xenografts.

J. Brueggen, C. Dominici, R. Riccardi, 2005, Cancer letters.

Mesenchymal chondrosarcoma: A case report in a four-year-old girl

C. Dominici, M. Castello, A. Clerico, 1985 .

KIT gene deletion in a gastrointestinal stromal tumor of the small intestine.

C. Dominici, S. Uccini, A. Testi, 2014, Journal of Pediatric Gastroenterology and Nutrition - JPGN.

Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.

C. Dominici, G. Kokai, S. Uccini, 2008, Anticancer research.

Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models.

C. Dominici, H. McDowell, R. Riccardi, 2006, International journal of cancer.

Molecular Biology of Childhood Solid Tumors

C. Dominici, P. Kogner, 1999 .

MOLECULAR BIOLOGY OF CHILDHOOD SOLID TUMORS Promises Maintained and Promises Postponed

C. Dominici, P. Kogner, 1999 .

Temozolomide in resistant or relapsed neuroblastoma

R. Cozza, A. Jenkner, A. Donfrancesco, 2005 .

Adrenocorticotropic hormone-secreting ganglioneuroblastoma associated with opsomyoclonic encephalopathy: a case report with immunohistochemical study.

C. Dominici, A. Tenore, L. Ruco, 1993, Medical and pediatric oncology.

Different pattern of matrix metalloproteinases expression in alveolar versus embryonal rhabdomyosarcoma.

L. Ravà, A. Donfrancesco, R. Boldrini, 2004, Journal of pediatric surgery.

Bilateral Rhabdomyomatous Tumor Relapsed as Typical Triphasic Wilms’ Tumor

C. Dominici, M. Castello, A. Clerico, 1987, Tumori.

Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide.

C. Dominici, B. Calabretta, G. Raschellà, 2008, Biochemical and biophysical research communications.